Trulieve Cannabis Corp.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Trulieve Cannabis Corp. engages in vertically integrated cannabis operations across the United States, focusing on cultivation, processing, distribution, and retail sales of medical and adult-use cannabis products. The company manufactures and distributes a wide range of cannabis花 products, including flower, concentrates, edibles, tinctures, topicals, and related ancillary products through company-owned dispensaries and, in some states, delivery channels, under multiple brand lines. Main products and services: - Cultivation and production: indoor and greenhouse cultivation; extraction and manufacturing of cannabis concentrates and oil-based products; cryo-freeze and other advanced processing methods; development of pre-rolls and finished consumer goods. - Retail and distribution: branded dispensaries offering direct-to-consumer sales of cannabis and derivative products; in-state medical and adult-use retail operations; managed delivery services where permitted; wholesale supply of products to partner retailers in select markets. - Product categories and brands: cannabis flower; concentrates (cannabis oils, distillates, and extracts); edibles (gummies, chocolates, baked goods); topicals (creams and balms); beverages and other derivative formats; consumer packaging and accessories; proprietary and partner brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One. - Ancillary services: quality control laboratories, post-harvest processing, packaging and labeling compliance, product development and R&D for new formats and dosage forms, and compliance support for regulated markets. Latest major company changes: - Strategic expansion in key markets through acquisitions and integrations of dispensaries or cultivation facilities to broaden geographic footprint and increase retail density; these moves include consolidations and divestitures of ancillary facilities as part of portfolio optimization. - Regulatory and market expansion efforts, including pursuing state-by-state growth with enhanced vertical integration capabilities, enabling more control over supply chains and product quality. - Product and branding updates across platforms, including new product launches and expansions of existing brand lines to address evolving consumer preferences and regulatory changes. - Corporate restructurings and leadership announcements aligned with growth strategies and capital efficiency goals, including realignment of operating segments to reflect state-level operations rather than traditional multi-segment reporting. Industry context and target markets: - Industry: cannabis, with operations spanning cultivation, processing, distribution, and retail within regulated U.S. markets. - Segments: medical cannabis, adult-use recreational cannabis, and derivative product trends such as concentrates, edibles, and topicals. - Customer base: registered medical cannabis patients and adult-use consumers in states where the company operates, with a growing emphasis on brand-based consumer shopping experiences at company-owned locations and compliance-backed delivery where available. - Geographic footprint: United States, with a focus on states permitting medical and/or adult-use cannabis sales; headquarters and primary operational hubs located in states with established cultivation and retail infrastructure. Founding and corporate structure: - Founding year: established prior to the 2010s as a pioneer in vertically integrated cannabis operations in the U.S. - Headquarters: United States (headquarters locations in states where the company maintains primary corporate functions and strategic leadership). - Subsidiaries/affiliates: operates through a network of owned and operated dispensaries, cultivation facilities, processing labs, and distribution centers; maintains relationships with state regulators and license holders to support regulated commerce. Note: Trulieve emphasizes a vertically integrated, asset-light approach where feasible within state-by-state regulatory constraints, leveraging in-house cultivation, processing, and retail networks to optimize product quality, supply chain efficiency, and direct-to-consumer accessibility. The company maintains a broad portfolio of products and brands designed to address diverse consumer preferences and medical needs while pursuing ongoing expansion and regulatory advancement across the U.S. market.
Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE
3 Marijuana Stocks For Investors To Consider
Trulieve Completes Redomicile from British Columbia to Delaware
Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy
Trulieve Cannabis Q2 Earnings Call Highlights
Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript
Trulieve Reports Second Quarter 2026 Results
Trulieve Reports Second Quarter 2026 Results
Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
Trulieve Announces August 2026 Event Participation
Best Marijuana Stocks to Add to Your August 2026 Watchlist
3 Top Marijuana Stocks That Can Make a Profitable Difference
Trulieve to Open Medical Cannabis Dispensary in Marco Island, Florida
Trulieve Cannabis Corp. to Hold Second Quarter 2026 Results Conference Call on August 7, 2026
Trulieve Named to TIME's America's Best Companies 2026 List
Better Cannabis Growth Stock: Trulieve or Vireo Growth
Trulieve Commemorates Georgia Medical Cannabis Launch with First Sale
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan
Trulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying?